Concepedia
Statistics
Publications
9
Citations
326
H-Index
Active since
2005
Affiliations
Cancer Society of New Zealand(Current)
University of Auckland
Leukemia & Lymphoma Society of Canada
Canada's Michael Smith Genome Sciences Centre
University of British Columbia
Jiechuang Su is an author at Cancer Society of New Zealand specializing in molecular oncology, medicine, and oncology.
Publications per year
2005–2022
The 2-Nitroimidazole EF5 Is a Biomarker for Oxidoreductases That Activate the Bioreductive Prodrug CEN-209 under Hypoxia
Jingli Wang, Annika Foehrenbacher, Jiechuang Su et al. · Clinical Cancer Research · 2011 · 66 citations · Full text
Medicine, Oncology, Pharmacology +17
Diflavin Oxidoreductases Activate the Bioreductive Prodrug PR-104A under Hypoxia
Christopher P. Guise, Maria R. Abbattista, Smitha R. Tipparaju et al. · Molecular Pharmacology · 2011 · 65 citations
Medicine, Biochemistry, Pharmacology +17
Dual Targeting of Hypoxia and Homologous Recombination Repair Dysfunction in Triple-Negative Breast Cancer
Francis W. Hunter, Huai‐Ling Hsu, Jiechuang Su et al. · Molecular Cancer Therapeutics · 2014 · 49 citations
PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL <sup>+</sup> human leukemia
Damian Lai, Min Chen, Jiechuang Su et al. · Science Translational Medicine · 2018 · 46 citations
Medicine, Oncology, Pharmacology +11
FSL-61 is a 6-nitroquinolone fluorogenic probe for one-electron reductases in hypoxic cells
Jiechuang Su, Christopher P. Guise, William R. Wilson · Biochemical Journal · 2013 · 27 citations
Life Sciences, Cell Biology, Molecular Biology +14
1–5 of 9